We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Removing a Regulatory Protein Eliminates the Link Between Stem Cell Differentiation and Matrix Rigidity

By LabMedica International staff writers
Posted on 05 Jul 2012
Removal of a master molecular regulator eliminates the requirement for stem cells to grow on a matrix of cardiac-like tissue in order to differentiate into heart cells.

Investigators at Johns Hopkins University (Baltimore, MD, USA) studied how the mechanical environment influenced tissue development and regeneration, which involved the selective proliferation of resident stem and precursor cells, differentiation into target somatic cell type, and spatial morphological organization. More...


They reported in June 5, 2012, online edition of the journal Science Signaling that multipotent cells derived from native cardiac tissue continually monitored the rigidity of the extracellular matrix upon which the cells were growing and showed enhanced proliferation, endothelial differentiation, and morphogenesis when the cell substratum rigidity closely matched that of myocardium.

Mechanical regulation of these diverse processes required p190RhoGAP, a guanosine triphosphatase–activating protein for RhoA (Ras homolog gene family, member A - a small GTPase protein known to regulate the actin cytoskeleton in the formation of stress fibers) acting through RhoA-dependent and -independent mechanisms. Natural or induced decreases in the abundance of p190RhoGAP triggered a series of developmental events by coupling cell-cell and cell-substratum interactions to genetic circuits controlling differentiation.

"It was the kind of master regulator of this process," said senior author Dr. Andre Levchenko, professor of biomedical engineering at Johns Hopkins University. "And an even bigger surprise was that if we directly forced this molecule to disappear, we no longer needed the special heart-matched surfaces. When the master regulator was missing, the stem cells started to form blood vessels, even on glass. In biology, finding a central regulator like this is like finding a pot of gold."

Related Links:
Johns Hopkins University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Portable POCT Blood Gas Analyzer
BD100
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.